z-logo
open-access-imgOpen Access
Hepatitis A and B Immunity and Vaccination in Chronic Hepatitis B and C Patients in a Large United States Cohort
Author(s) -
Emily Henkle,
Mei Lü,
Loralee B. Rupp,
Joseph A. Boscarino,
Vinutha Vijayadeva,
Mark A. Schmidt,
Stuart C. Gordon,
Scott D. Holmberg,
Eyasu H. Teshale,
Philip R. Spradling,
Anne C. Moorman,
David R. Nerenz,
Lois Lamerato,
na Akkerman,
Nancy Oja-Tebbe,
Chad Cogan,
Dana Larkin,
Zahra Daar,
J. B. Leader,
Robert E. Smith,
Cynthia Nakasato,
K. E. Sylva,
J. V. Parker,
Márcia Moura Schmidt,
T. L. Dodge,
Erin Keast
Publication year - 2014
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciu879
Subject(s) - medicine , vaccination , hepatitis b , immunology , hepatitis a , hepatitis , immunity , hepatitis b vaccine , hepatitis c , population , immune system , virology , hepatitis b virus , hbsag , virus , environmental health
Hepatitis A and B vaccines are effective in preventing superinfection and sequelae in patients with chronic hepatitis B or C. We describe immunity and vaccination against hepatitis A and B in chronic hepatitis patients from the US Chronic Hepatitis Cohort Study.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom